Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physiological adaptation pathways refer to the integrated network of biological processes that allow an organism or cell to maintain internal stability, or homeostasis, in the face of environmental changes or internal stressors (StatPearls, 2023). These pathways encompass a wide array of mechanisms, including the hypoxia-inducible factor (HIF) signaling pathway, the heat shock response, and the integrated stress response, which collectively ensure survival under conditions such as nutrient deprivation or oxidative stress (Nature Reviews Molecular Cell Biology, 2020). In various disease states, particularly oncology, these pathways are often hijacked by cells to promote survival in hostile microenvironments and to develop resistance against therapeutic interventions (Journal of Clinical Investigation, 2018). However, 'Physiological adaptation pathways' is a broad conceptual category rather than a specific molecular target like a single receptor or enzyme (NIH, 2022). Consequently, it is not considered a discrete therapeutic target; instead, drug discovery efforts focus on modulating specific proteins or nodes within these pathways to achieve clinical efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physiological adaptation pathways.